Your GLP-1 receptors have had two months to adapt
Blood Glucose Levels It is accepted by the Food and Drug Administration ( FDA ) that, one role of GLP-1 is to prompt the body to produce more insulin, which reduces blood glucose (sugar) . Because blood glucose levels are a key consideration in control of diabetes and other health conditions, the Study measured blood glucose levels at each of the 19 sample time points
Since drugs like Zepbound and Wegovy entered the weight-loss arena, and the high demand for the diabetes-turned-diet drugs pushed them into short supply, a new world centered on these medications has emerged
Nearly identical assertions are also being pursued against other GLP-1 receptor agonists, such as Wegovy, Mounjaro, Rybelsus, Saxenda, and Trulicity
Also, changes in appetite and how full you feel can show how the medication is working